Effects of Food Intake on the Pharmacokinetic Properties of Mirabegron Oral Controlled-Absorption System: A Single-Dose, Randomized, Crossover Study in Healthy Adults
Authors:
- 1 March 2013
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 35 (3) , 333-341
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Single dose pharmacokinetics and absolute bioavailability of mirabegron, a ?3-adrenoceptor agonist for treatment of overactive bladderInt. Journal of Clinical Pharmacology and Therapeutics, 2012
- Absorption, Metabolism and Excretion of [14C]Mirabegron (YM178), a Potent and Selective β3-Adrenoceptor Agonist, after Oral Administration to Healthy Male VolunteersDrug Metabolism and Disposition, 2012
- 886 THE EFFICACY AND TOLERABILITY OF MIRABEGRON IN PATIENTS WITH OVERACTIVE BLADDER – RESULTS FROM A EUROPEAN–AUSTRALIAN PHASE III TRIALEuropean Urology Supplements, 2011
- 885 THE EFFICACY AND SAFETY OF MIRABEGRON IN PATIENTS WITH OVERACTIVE BLADDER SYNDROME – RESULTS FROM A NORTH-AMERICAN PHASE III TRIALEuropean Urology Supplements, 2011
- 774 DOSE-RANGING STUDY OF ONCE-DAILY MIRABEGRON (YM178), A NOVEL SELECTIVE β3-ADRENOCEPTOR AGONIST, IN PATIENTS WITH OVERACTIVE BLADDER (OAB)European Urology Supplements, 2010
- Reviewing the ICS 2002 terminology report: The ongoing debateNeurourology and Urodynamics, 2009
- β3‐Adrenoceptors in urinary bladderNeurourology and Urodynamics, 2007
- Effect of (R)-2-(2-Aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} Acetanilide (YM178), a Novel Selective β3-Adrenoceptor Agonist, on Bladder FunctionThe Journal of Pharmacology and Experimental Therapeutics, 2007
- The Development of the Oral Controlled Absorption System (OCAS®): A New Improved Formulation of TamsulosinEuropean Urology Supplements, 2005
- The Pharmacokinetic Profile of Tamsulosin Oral Controlled Absorption System (OCAS®)European Urology Supplements, 2005